Get started
Author

Elisa Vinci

The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches
2020 · Fabio Salvatore Macaluso, Walter Fries, et al. · Inflammatory Bowel Diseases · 49
SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501
2021 · Fabio Salvatore Macaluso, Maria Cappello, et al. · Journal of Gastroenterology and Hepatology · 23
Letter: SPOSIB SB2—a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2
2018 · Fabio Salvatore Macaluso, Maria Cappello, et al. · Alimentary Pharmacology & Therapeutics · 9
PDF
P.07.6 Low-fodmaps Diet Improves Intestinal Symptoms in Ibd Patients With Disease Remission: Randomized Case-control Study
2018 · G. Tapete, N. De Bortoli, et al. · Digestive and Liver Disease · 5
P425 SPOSIB SB2: a Sicilian prospective observational study of patients with inflammatory bowel disease treated with infliximab biosimilar SB2
2020 · F S Macaluso, W Fries, et al. · Journal of Crohn s and Colitis · 2
Sposab Abp 501 - a Sicilian Prospective Observational Study of Patients With Inflammatory Bowel Disease Treated With Adalimumab Biosimilar Abp 501
2021 · Fabio Salvatore Macaluso, Maria Cappello, et al. · Gastroenterology · 1
P621 Efficacy and safety of golimumab in ulcerative colitis. Preliminary data from a multicenter Italian study
2017 · F. Bossa, M.R. Valvano, et al. · Journal of Crohn s and Colitis · 1
P412 The Sicilian network of biological therapy in inflammatory bowel disease: preliminary data on efficacy
2017 · A. Orlando, F.S. Macaluso, et al. · Journal of Crohn s and Colitis · 1
Af.57 Sposab Abp 501: a Sicilian Prospective Observational Study of Patients With Inflammatory Bowel Disease Treated With Adalimumab Biosimilar Abp 501
2021 · F.S. Macaluso, M. Cappello, et al. · Digestive and Liver Disease
P436 SPOSAB ABP 501 - A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501
2021 · F Macaluso, M Cappello, et al. · Journal of Crohn s and Colitis
Sposab Abp 501 - a Sicilian Prospective Observational Study of Patients With Inflammatory Bowel Disease Treated With Adalimumab Biosimilar Abp 501
2021 · Fabio Salvatore Macaluso, Maria Cappello, et al. · Inflammatory Bowel Diseases
Oc.12.1 Sposib Sb2 - a Sicilian Prospective Observational Study of Patients With Inflammatory Bowel Disease Treated With Infliximab Biosimilar Sb2
2020 · F.S. Macaluso, W. Fries, et al. · Digestive and Liver Disease
Oc.12.3 Sposib Sb2 – a Sicilian Prospective Observational Study of Patients With Inflammatory Bowel Disease Treated With Infliximab Biosimilar Sb2 (flixabi®): Interim Analysis
2019 · F.S. Macaluso, M. Cappello, et al. · Digestive and Liver Disease
P737 SPOSIB SB2: A Sicilian prospective observational study of patients with inflammatory bowel disease treated with infliximab Biosimilar SB2 (Flixabi®): interim analysis
2019 · F S Macaluso, M Cappello, et al. · Journal of Crohn s and Colitis
OC.06.2: The Sicilian Network of Biological Therapy in Inflammatory Bowel Disease: Preliminary Data from a Prospective Study on Efficacy and Safety
2017 · A. Orlando, W. Fries, et al. · Digestive and Liver Disease
PDF
Works count: 15
Citation count: 91
H-index: 4
I10-index: 2
Year
Topic
Type